Project Narrative Glioblastoma (GBM) is one of the most devastating human cancers that almost always recurs due to the presence of invasive therapy-resistant infiltrating cancer cells at the tumor margin. Magnetic hyperthermia therapy (MHT) is a powerful, nanotechnology-based treatment that may enhance the effects of radiation therapy (RT) and chemotherapy against infiltrating GBM tumors.
|Effective start/end date||1/12/19 → 30/11/22|
- National Cancer Institute: $653,976.00
- National Cancer Institute: $706,027.00
- National Cancer Institute: $619,800.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.